Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMBR | P28336 | 2/20 | 0.61 |
| ▸ | GRPR | P30550 | 2/20 | 0.61 |
| ▸ | CXCL8 | P10145 | 9/20 | 0.59 |
| ▸ | CTSL | P07711 | 2/20 | 0.59 |
| ▸ | CTSS | P25774 | 2/20 | 0.59 |
| ▸ | CTSK | P43235 | 2/20 | 0.59 |
| ▸ | CTSH | P09668 | 1/20 | 0.59 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.57 |
| ▸ | GLP1R | P43220 | 3/20 | 0.57 |
| ▸ | GCGR | P47871 | 3/20 | 0.57 |
| ▸ | F2 | P00734 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29421992 | 0.87 | CXCR4 (0.66) | GRPRCXCL8KISS1RGLP1R | |
| SCHEMBL29689766 | 0.87 | CXCR4 (0.66) | GRPRCXCL8KISS1RGLP1R | |
| SCHEMBL31053728 | 0.87 | KISS1R (0.56) | NMBRGRPRCXCL8CTSLCTSS | |
| SCHEMBL30432609 | 0.85 | CXCR4 (0.67) | NMBRGRPRCXCL8CTSLCTSS | |
| SCHEMBL30072008 | 0.85 | F2 (0.64) | NMBRGRPRCXCL8KISS1RGLP1R | |
| SCHEMBL29416123 | 0.85 | CXCR4 (0.60) | NMBRGRPRCXCL8KISS1RGLP1R | |
| SCHEMBL30431758 | 0.85 | C5AR1 (0.69) | NMBRGRPRKISS1RGLP1RGCGR | |
| SCHEMBL29663694 | 0.84 | CXCL8 (0.59) | NMBRGRPRCXCL8CTSLCTSS | |
| SCHEMBL31000909 | 0.84 | CXCL8 (0.64) | CXCL8GLP1RGCGR | |
| SCHEMBL30968310 | 0.84 | GLP1R (0.68) | NMBRGRPRGLP1RGCGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250381242-A1 | ANTIMICROBIAL PEPTIDES AGAINST CITRUS GREENING | INVAIO SCIENCES INC (US) | 2025-12-18 | — | — | US | disclosed |
| US-20250382332-A1 | NOVEL ALPHA-FACTOR BASED PEPTIDES WITH ANTIFUNGAL ACTIVITY | INVAIO SCIENCES INC (US) | 2025-12-18 | — | — | US | disclosed |
| US-20250287945-A1 | COMPOSITIONS FOR FUNGAL CONTROL AND RELATED METHODS | FLAGSHIP PIONEERING INNOVATIONS VII, LLC (US) | 2025-09-18 | — | — | US | disclosed |
| US-20240368664-A1 | LIVE YEAST BIOSENSORS AND METHODS OF USE THEREOF | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2024-11-07 | — | — | US | disclosed |
| EP-4373840-A1 | COMPOSITIONS FOR FUNGAL CONTROL AND RELATED METHODS | Flagship Pioneering Innovations VII, LLC (US) | 2024-05-29 | — | — | EP | disclosed |
| EP-4352513-A2 | LIVE YEAST BIOSENSORS AND METHODS OF USE THEREOF | The Trustees Of Columbia University In The City Of New York (US) | 2024-04-17 | — | — | EP | disclosed |
| US-11899014-B2 | Detection of analytes using live cells | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2024-02-13 | — | — | US | disclosed |
| WO-2023004435-A1 | COMPOSITIONS FOR FUNGAL CONTROL AND RELATED METHODS | FLAGSHIP PIONEERING INNOVATIONS VII, LLC (US) | 2023-01-26 | — | — | WO | disclosed |
| WO-2022246003-A2 | LIVE YEAST BIOSENSORS AND METHODS OF USE THEREOF | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2022-11-24 | — | — | WO | disclosed |
| US-11473073-B2 | Aminopeptidases for protein hydrolyzates | DUPONT NUTRITION BIOSCIENCES APS (DK) | 2022-10-18 | — | — | US | disclosed |
| US-20220119825-A1 | SCALABLE PEPTIDE-GPCR INTERCELLULAR SIGNALING SYSTEMS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2022-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220119825-A1 | SCALABLE PEPTIDE-GPCR INTERCELLULAR SIGNALING SYSTEMS | SCTR, GRPR, RGS8 | NMBR 202/4885GRPR 2/4885CXCL8 755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.